Alaunos Therapeutics, INC. (TCRT) — S-1 Filings
All S-1 filings from Alaunos Therapeutics, INC.. Browse 1 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (1)
-
Alaunos Pivots to Obesity, Seeks $25M Amid Oncology Wind-Down
— Oct 22, 2025 Risk: high
Alaunos Therapeutics, Inc. (TCRT) is undergoing a significant strategic pivot, shifting from clinical-stage oncology cell therapy to a preclinical small molecul
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX